Paul Ross

10PUBLICATIONS
109CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsCancer geneticsTumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 27, 2025
Implementation of mass pharmacogenetic testing: Dihydropyrimidine dehydrogenase testing prior to fluoropyrimidine treatment for patients.

Nisha Shaunak, Jessica Keen, Anna Kim

|Dec 05, 2024
Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial.

Daniel H Palmer, Richard Jackson, Christoph Springfeld

|Oct 31, 2024
Large-Scale Pharmacogenomics Analysis of Patients With Cancer Within the 100,000 Genomes Project Combining Whole-Genome Sequencing and Medical Records to Inform Clinical Practice.

Ivone U S Leong, Claudia P Cabrera, Valentina Cipriani

|Apr 05, 2024
Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study.

David J Pinato, Antonio D'Alessio, Claudia Angela Maria Fulgenzi

|Feb 10, 2023
ANCHOR CRC: Results From a Single-Arm, Phase II Study of Encorafenib Plus Binimetinib and Cetuximab in Previously Untreated <i>BRAF</i><sup>V600E</sup>-Mutant Metastatic Colorectal Cancer.

Eric Van Cutsem, Julien Taieb, Rona Yaeger

Pageof 2